2 results
Approved WMORecruiting
The study the safety and imaging characteristics of GE-137
Approved WMORecruiting
1. To evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period